Is radioiodine administration in patients with papillary thyroid multifocal microcarcinoma unnecessary?

Radioiodine (RAI) has played a crucial role in differentiated thyroid cancer treatment for more than 60years. However, the use of RAI administration in patients with papillary thyroid microcarcinoma (even multifocal) is now being widely discussed and often not recommended. In accordance with Europea...

Descripción completa

Detalles Bibliográficos
Autores principales: Krčálová, Eva, Horáček, Jiří, Kudlej, Lubomír, Rousková, Viera, Michlová, Blanka, Vyhnánková, Irena, Doležal, Jiří, Malý, Jaroslav, Žák, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2016
Materias:
Error in Diagnosis/Pitfalls and Caveats
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870506/
https://www.ncbi.nlm.nih.gov/pubmed/27252861
http://dx.doi.org/10.1530/EDM-15-0138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870506/
https://www.ncbi.nlm.nih.gov/pubmed/27252861
http://dx.doi.org/10.1530/EDM-15-0138

Ejemplares similares